Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

284 ARTÍCULOS , VIENDO DEL 271 AL 284

CAPRIN1 Pro512Leu Variant Causes Childhood Dementia, Myoclonus-Ataxia, and Sensorimotor Neuropathy

Bove R, Torella A, Novelli M, Ricciardi G, Pollini L, Masuelli L, Bei R, Zanobio M, Pisani F, Nigro V, Leuzzi V, Galosi S.

Mov Disord Clin Pract. 2025 May;12(5):694-698. doi: 10.1002/mdc3.14347. Epub 2025 Jan 29.

Movement Disorders in Central Nervous System Tuberculosis: A Systematic Review

Garg RK, Pandey S, Mahdi RA, Singhal S.

Can J Neurol Sci. 2025 Sep 29:1-10. doi: 10.1017/cjn.2025.10436. Online ahead of print.

Three Cases of Spinocerebellar Ataxia Type 2 (SCA2) and Pediatric Literature Review: Do Not Forget Trinucleotide Repeat Disorders in Childhood-Onset Progressive Ataxia

Sartorelli J, Pomponi MG, Garone G, Vasco G, Cumbo F, Colona VL, D'Amico A, Bertini E, Nicita F.

Brain Sci. 2025 Feb 4;15(2):156. doi: 10.3390/brainsci15020156.

Phenotypic Diversity in Stress-induced Childhood-Onset Neurodegeneration with Variable Ataxia and Seizures: Novel Associations with Parkinsonism, Icthyosis and Cataract

Nandana J, Fasaludeen A, Kumar AA, Vijayaraghavan A, Nair SS, Cherian A, Menon RN, Sundaram S.

Cerebellum. 2025 Jun 10;24(4):112. doi: 10.1007/s12311-025-01866-3.

Movement Disorders after Dengue Virus Infection: A Scoping Review

Rosca EC, Garg D, Perez-Lloret S, Mohamed Ibrahim N, Phokaewvarangkul O, Sringean J, Holla V, Yadav R, Desai S, Pal PK.

Mov Disord. 2025 Apr;40(4):583-604. doi: 10.1002/mds.30142. Epub 2025 Feb 8.

Developmental and Epileptic Encephalopathy as a Novel Clinical Hallmark of SCA21

Mastrangelo M, Ricciardi G, Greco C, Bove R, Pollini L, Tolve M, Galosi S, Pisani F.

Neuropediatrics. 2025 Dec;56(6):404-407. doi: 10.1055/a-2646-2535. Epub 2025 Jul 2.

The Genotypic and Phenotypic Spectrum of GOSR2 Mutations: Clinical and Pathophysiological Insights

Polet SS, Siegal EZ, Fuchs SA, Tijssen MAJ, de Koning TJ.

J Inherit Metab Dis. 2025 Nov;48(6):e70115. doi: 10.1002/jimd.70115.

A Scoping Review of POLG-Related Cerebellar Ataxia: Insights and Clinical Perspectives

Kalampokini S, Keramidiotis I, Ravanidis S, Lochner P, Kimiskidis VK, Hadjigeorgiou GM.

Tremor Other Hyperkinet Mov (N Y). 2025 Nov 10;15:55. doi: 10.5334/tohm.1027. eCollection 2025.

Clinical Features and Outcomes of Glutamic Acid Decarboxylase-65 Antibody-Associated Pure Cerebellar Ataxia and Stiff Person Syndrome Spectrum Disorders: A Single-Center Cohort Study

Krett JD, Wang Y, Miles A, Chen HR, Afshar H, Elfasi A, Lin DD, Newsome SD.

Eur J Neurol. 2025 May;32(5):e70166. doi: 10.1111/ene.70166.

Anti-Glutamic Acid Decarboxylase 65 (GAD65) Antibodies and Neurological Syndromes

Mohammadzadeh O, Fahimzadeh N, Elhami F, Shobeiri SS.

J Gene Med. 2025 Oct;27(10):e70039. doi: 10.1002/jgm.70039.

Clinical and biochemical footprints of inherited metabolic diseases: Ia. Movement disorders, updated

Peacock DJSJ, Ferreira CR, Horvath G, Hoffmann GF, Blau N, Ebrahimi-Fakhari D.

Mol Genet Metab. 2025 May;145(1):109084. doi: 10.1016/j.ymgme.2025.109084. Epub 2025 Mar 18.

Movement Disorders in Toxoplasmosis: A Systematic Review

Garg RK, Pandey S, Agarwal M, Singhal S.

Tremor Other Hyperkinet Mov (N Y). 2025 Sep 30;15:48. doi: 10.5334/tohm.1093. eCollection 2025.

AFG3L2-Related Neurologic Disorders

Coarelli G, Mouraux C.

2011 May 17 [updated 2025 Sep 18]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

KCNC1-Related Disorders

Ginn N, Goldberg EM.

2025 Dec 18. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias